Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec 15:313:118-122.
doi: 10.1016/j.jneuroim.2017.10.006. Epub 2017 Oct 13.

Impact of immunotherapy among patients with melanoma brain metastases managed with radiotherapy

William A Stokes  1 , David C Binder  2 , Bernard L Jones  3 , Ayman J Oweida  4 , Arthur K Liu  5 , Chad G Rusthoven  6 , Sana D Karam  7
Affiliations

Impact of immunotherapy among patients with melanoma brain metastases managed with radiotherapy

William A Stokes et al. J Neuroimmunol. .

Abstract

Background: Patients with melanoma brain metastases (MBM) have been excluded from trials evaluating immunotherapy in melanoma. As such, immunotherapy's role in MBM is poorly understood, particularly in combination with radiotherapy.

Methods: The National Cancer Database was queried for patients with MBM receiving brain radiotherapy. They were classified according to immunotherapy receipt. Multivariate Cox regression was performed to identify factors associated with survival.

Results: Among 1287 patients, 185 received immunotherapy. Factors associated with improved survival included younger age, academic facility, lower extracranial disease burden, stereotactic radiotherapy, chemotherapy, and immunotherapy.

Conclusions: Adding immunotherapy to radiotherapy for MBM is associated with improved survival.

Keywords: Brain metastases; Immunotherapy; Melanoma; Stereotactic radiosurgery; Whole-brain radiotherapy.

PubMed Disclaimer

Publication types

LinkOut - more resources